Interaction between celecoxib and docetaxel or cisplatin in human cell lines of ovarian cancer and colon cancer is independent of COX-2 expression levels

M.N. Bijman; C.A. Hermelink; M.P. van Berkel; A.C. Laan; M.L. Janmaat; G.J. Peters; E. Boven

doi:https://doi.org/10.1016/j.bcp.2007.09.005

Interaction between celecoxib and docetaxel or cisplatin in human cell lines of ovarian cancer and colon cancer is independent of COX-2 expression levels

M.N. Bijman, C.A. Hermelink, M.P. van Berkel, A.C. Laan, M.L. Janmaat, G.J. Peters, E. Boven

Research output: Contribution to journal › Article › Academic › peer-review

36 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	427-437
Journal	Biochemical Pharmacology
Volume	75
Issue number	2
DOIs	https://doi.org/10.1016/j.bcp.2007.09.005
Publication status	Published - 2008

Access to Document

https://doi.org/10.1016/j.bcp.2007.09.005

Cite this

@article{97bcb491723b40b89fbcbfb874d10e43,

title = "Interaction between celecoxib and docetaxel or cisplatin in human cell lines of ovarian cancer and colon cancer is independent of COX-2 expression levels",

author = "M.N. Bijman and C.A. Hermelink and {van Berkel}, M.P. and A.C. Laan and M.L. Janmaat and G.J. Peters and E. Boven",

year = "2008",

doi = "https://doi.org/10.1016/j.bcp.2007.09.005",

language = "Undefined/Unknown",

volume = "75",

pages = "427--437",

journal = "Biochemical Pharmacology",

issn = "0006-2952",

publisher = "Elsevier Inc.",

number = "2",

}

TY - JOUR

T1 - Interaction between celecoxib and docetaxel or cisplatin in human cell lines of ovarian cancer and colon cancer is independent of COX-2 expression levels

AU - Bijman, M.N.

AU - Hermelink, C.A.

AU - van Berkel, M.P.

AU - Laan, A.C.

AU - Janmaat, M.L.

AU - Peters, G.J.

AU - Boven, E.

PY - 2008

Y1 - 2008

U2 - https://doi.org/10.1016/j.bcp.2007.09.005

DO - https://doi.org/10.1016/j.bcp.2007.09.005

M3 - Article

SN - 0006-2952

VL - 75

SP - 427

EP - 437

JO - Biochemical Pharmacology

JF - Biochemical Pharmacology

IS - 2

ER -